| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.987 | 0.003 | 0.995 | Cyclophilin D inhibitor | 0.995 0.003 DBMET01300 0.982 0.003 DBMET01301 0.987 0.003 DBMET01304 0.987 0.003 DBMET01305 0.985 0.003 DBMET01306 0.978 0.004 DBMET01302 0.985 0.003 DBMET01303 0.984 0.003 DBMET01307 | DBMET01300 | |
| 0.92 | 0.001 | 0.98 | Insulin sensitizer | 0.656 0.003 DBMET01300 0.973 0.001 DBMET01301 0.956 0.001 DBMET01304 0.98 0.001 DBMET01305 0.877 0.002 DBMET01306 0.932 0.001 DBMET01302 0.878 0.002 DBMET01303 0.726 0.002 DBMET01307 | DBMET01305 | |
| 0.902 | 0.003 | 0.931 | Hypoglycemic | 0.931 0.003 DBMET01300 0.891 0.003 DBMET01301 0.905 0.003 DBMET01304 0.901 0.003 DBMET01305 0.894 0.003 DBMET01306 0.887 0.003 DBMET01302 0.898 0.003 DBMET01303 0.895 0.003 DBMET01307 | DBMET01300 | |
| 0.871 | 0 | 0.952 | Thiazolidinedione | 0.952 0 DBMET01300 0.836 0 DBMET01301 0.676 0 DBMET01304 0.672 0 DBMET01305 0.551 0 DBMET01306 0.658 0 DBMET01302 0.823 0 DBMET01303 0.808 0 DBMET01307 | DBMET01300 | |
| 0.832 | 0.002 | 0.86 | Peroxisome proliferator-activated receptor gamma agonist | 0.852 0.002 DBMET01300 0.664 0.003 DBMET01301 0.814 0.002 DBMET01304 0.86 0.002 DBMET01305 0.763 0.002 DBMET01306 0.625 0.003 DBMET01302 0.642 0.003 DBMET01303 0.809 0.002 DBMET01307 | DBMET01305 | |
| 0.764 | 0.004 | 0.823 | Hypolipemic | 0.823 0.004 DBMET01300 0.751 0.004 DBMET01301 0.771 0.004 DBMET01304 0.774 0.004 DBMET01305 0.758 0.004 DBMET01306 0.68 0.005 DBMET01302 0.766 0.004 DBMET01303 0.737 0.004 DBMET01307 | DBMET01300 | |
| 0.614 | 0.019 | 0.74 | Antiobesity | 0.564 0.025 DBMET01300 0.659 0.014 DBMET01301 0.637 0.016 DBMET01304 0.649 0.015 DBMET01305 0.728 0.009 DBMET01306 0.461 0.046 DBMET01302 0.74 0.008 DBMET01303 0.514 0.034 DBMET01307 | DBMET01303 | |
| 0.468 | 0.005 | 0.538 | Sodium/bile acid cotransporter inhibitor | 0.538 0.003 DBMET01300 0.467 0.005 DBMET01301 0.471 0.005 DBMET01304 0.485 0.004 DBMET01305 0.462 0.006 DBMET01306 0.466 0.005 DBMET01302 0.463 0.006 DBMET01303 0.461 0.006 DBMET01307 | DBMET01300 | |
| 0.407 | 0.002 | 0.656 | Peroxisome proliferator-activated receptor gamma antagonist | 0.183 0.004 DBMET01300 0.535 0.002 DBMET01301 0.582 0.002 DBMET01304 0.656 0.002 DBMET01305 0.302 0.003 DBMET01306 0.372 0.003 DBMET01302 0.283 0.003 DBMET01303 0.232 0.004 DBMET01307 | DBMET01305 | |
| 0.388 | 0.004 | 0.702 | Aldose reductase inhibitor | 0.702 0.002 DBMET01300 0.429 0.004 DBMET01301 0.409 0.004 DBMET01304 0.497 0.003 DBMET01305 0.341 0.004 DBMET01306 0.434 0.004 DBMET01302 0.425 0.004 DBMET01303 0.391 0.004 DBMET01307 | DBMET01300 | |
| 0.367 | 0.007 | 0.463 | Insulin secretagoues | 0.453 0.005 DBMET01300 0.237 0.022 DBMET01301 0.441 0.005 DBMET01304 0.463 0.005 DBMET01305 0.329 0.01 DBMET01306 0.224 0.026 DBMET01302 0.213 0.03 DBMET01303 0.327 0.01 DBMET01307 | DBMET01305 | |
| 0.359 | 0.004 | 0.472 | ABCA1 expression enhancer | 0.472 0.004 DBMET01300 0.251 0.006 DBMET01301 0.425 0.004 DBMET01304 0.438 0.004 DBMET01305 0.285 0.005 DBMET01306 0.267 0.005 DBMET01302 0.233 0.007 DBMET01303 0.301 0.005 DBMET01307 | DBMET01300 | |
| 0.353 | 0.011 | 0.587 | NOS3 expression enhancer | 0.587 0.004 DBMET01300 0.332 0.013 DBMET01301 0.408 0.008 DBMET01304 0.337 0.013 DBMET01305 0.265 0.024 DBMET01306 0.347 0.012 DBMET01302 0.269 0.023 DBMET01303 0.298 0.018 DBMET01307 | DBMET01300 | |
| 0.377 | 0.043 | 0.469 | Lipoxygenase inhibitor | 0.469 0.023 DBMET01300 0.337 0.055 DBMET01301 0.371 0.045 DBMET01304 0.45 0.026 DBMET01305 0.366 0.046 DBMET01306 0.405 0.036 DBMET01302 0.325 0.059 DBMET01303 0.429 0.03 DBMET01307 | DBMET01300 | |
| 0.4 | 0.067 | 0.496 | Prostaglandin dehydrogenase inhibitor | 0.496 0.042 DBMET01300 0.408 0.065 DBMET01304 0.238 0.133 DBMET01305 0.307 0.098 DBMET01302 0.378 0.074 DBMET01307 | DBMET01300 | |
| 0.298 | 0.003 | 0.609 | Free fatty acid receptor 1 agonist | 0.609 0.002 DBMET01300 0.222 0.003 DBMET01301 0.288 0.003 DBMET01304 0.426 0.002 DBMET01305 0.252 0.003 DBMET01306 0.243 0.003 DBMET01302 0.224 0.003 DBMET01303 0.249 0.003 DBMET01307 | DBMET01300 | |
| 0.289 | 0.003 | 0.541 | Peroxisome proliferator-activated receptor alpha agonist | 0.147 0.006 DBMET01300 0.307 0.003 DBMET01301 0.403 0.003 DBMET01304 0.541 0.002 DBMET01305 0.219 0.004 DBMET01306 0.203 0.004 DBMET01302 0.168 0.005 DBMET01303 0.177 0.005 DBMET01307 | DBMET01305 | |
| 0.286 | 0.004 | 0.487 | Adrenaline agonist | 0.364 0.003 DBMET01300 0.466 0.002 DBMET01301 0.349 0.003 DBMET01304 0.298 0.004 DBMET01305 0.466 0.002 DBMET01306 0.173 0.01 DBMET01302 0.487 0.002 DBMET01303 0.207 0.006 DBMET01307 | DBMET01303 | |
| 0.25 | 0.025 | 0.341 | Bone formation stimulant | 0.341 0.013 DBMET01300 0.17 0.046 DBMET01301 0.233 0.028 DBMET01304 0.291 0.018 DBMET01305 0.169 0.047 DBMET01306 0.215 0.032 DBMET01302 0.121 0.085 DBMET01303 0.184 0.04 DBMET01307 | DBMET01300 | |
| 0.271 | 0.054 | 0.392 | Cyclic AMP phosphodiesterase inhibitor | 0.392 0.018 DBMET01300 0.246 0.066 DBMET01301 0.337 0.029 DBMET01304 0.286 0.047 DBMET01305 0.276 0.052 DBMET01306 0.184 0.107 DBMET01302 0.208 0.088 DBMET01303 0.165 0.129 DBMET01307 | DBMET01300 | |
| 0.303 | 0.088 | 0.384 | Calcium channel activator | 0.384 0.031 DBMET01300 0.228 0.174 DBMET01301 0.344 0.054 DBMET01304 0.329 0.065 DBMET01305 0.356 0.046 DBMET01306 0.271 0.123 DBMET01303 0.275 0.118 DBMET01307 | DBMET01300 | |
| 0.238 | 0.029 | 0.462 | Lipid peroxidase inhibitor | 0.462 0.007 DBMET01300 0.197 0.043 DBMET01301 0.241 0.029 DBMET01304 0.239 0.029 DBMET01305 0.235 0.03 DBMET01306 0.254 0.026 DBMET01302 0.198 0.043 DBMET01303 0.215 0.036 DBMET01307 | DBMET01300 | |
| 0.212 | 0.009 | 0.403 | AMP-activated protein kinase stimulant | 0.322 0.005 DBMET01300 0.129 0.042 DBMET01301 0.403 0.004 DBMET01304 0.346 0.004 DBMET01305 0.16 0.022 DBMET01306 0.114 0.054 DBMET01302 0.091 0.083 DBMET01303 0.153 0.026 DBMET01307 | DBMET01304 | |
| 0.198 | 0.003 | 0.356 | Peroxisome proliferator-activated receptor alpha antagonist | 0.082 0.005 DBMET01300 0.101 0.004 DBMET01301 0.288 0.002 DBMET01304 0.356 0.002 DBMET01305 0.123 0.004 DBMET01306 0.074 0.006 DBMET01302 0.026 0.013 DBMET01303 0.115 0.004 DBMET01307 | DBMET01305 | |
| 0.263 | 0.074 | 0.538 | Cardiotonic | 0.281 0.065 DBMET01300 0.538 0.012 DBMET01301 0.223 0.1 DBMET01304 0.226 0.098 DBMET01305 0.211 0.109 DBMET01306 0.483 0.017 DBMET01303 0.171 0.151 DBMET01307 | DBMET01301 | |
| 0.183 | 0.004 | 0.26 | Peroxisome proliferator-activated receptor delta antagonist | 0.178 0.004 DBMET01300 0.056 0.008 DBMET01301 0.196 0.004 DBMET01304 0.26 0.004 DBMET01305 0.099 0.005 DBMET01306 0.063 0.008 DBMET01302 0.043 0.013 DBMET01303 0.134 0.005 DBMET01307 | DBMET01305 | |
| 0.208 | 0.037 | 0.375 | Interleukin 6 antagonist | 0.375 0.009 DBMET01300 0.207 0.037 DBMET01301 0.167 0.067 DBMET01304 0.219 0.032 DBMET01305 0.167 0.067 DBMET01306 0.204 0.038 DBMET01302 0.167 0.068 DBMET01303 0.19 0.047 DBMET01307 | DBMET01300 | |
| 0.199 | 0.028 | 0.203 | Neurotrophic factor | 0.183 0.036 DBMET01300 0.203 0.026 DBMET01301 0.137 0.072 DBMET01304 0.185 0.035 DBMET01305 0.12 0.095 DBMET01306 0.196 0.029 DBMET01302 0.156 0.054 DBMET01307 | DBMET01301 | |
| 0.174 | 0.004 | 0.386 | Estrogen-related receptor alpha antagonist | 0.386 0.002 DBMET01300 0.144 0.004 DBMET01301 0.15 0.004 DBMET01304 0.144 0.004 DBMET01305 0.132 0.004 DBMET01306 0.165 0.004 DBMET01302 0.136 0.004 DBMET01303 0.151 0.004 DBMET01307 | DBMET01300 | |
| 0.15 | 0.005 | 0.278 | Maillard reaction inhibitor | 0.278 0.003 DBMET01300 0.139 0.007 DBMET01301 0.168 0.005 DBMET01304 0.163 0.005 DBMET01305 0.149 0.006 DBMET01306 0.135 0.008 DBMET01302 0.138 0.007 DBMET01303 0.145 0.006 DBMET01307 | DBMET01300 | |
| 0.225 | 0.086 | 0.3 | Vasodilator | 0.258 0.065 DBMET01300 0.176 0.126 DBMET01301 0.3 0.048 DBMET01304 0.224 0.087 DBMET01305 0.182 0.12 DBMET01306 0.163 0.139 DBMET01307 | DBMET01304 | |
| 0.142 | 0.011 | 0.228 | Lipase inhibitor | 0.228 0.005 DBMET01300 0.116 0.02 DBMET01301 0.137 0.012 DBMET01304 0.134 0.013 DBMET01305 0.123 0.017 DBMET01306 0.127 0.015 DBMET01302 0.109 0.023 DBMET01303 0.134 0.013 DBMET01307 | DBMET01300 | |
| 0.121 | 0.003 | 0.317 | Beta adrenoreceptor agonist | 0.198 0.003 DBMET01300 0.317 0.002 DBMET01301 0.224 0.002 DBMET01304 0.162 0.003 DBMET01305 0.293 0.002 DBMET01306 0.063 0.007 DBMET01302 0.294 0.002 DBMET01303 0.079 0.004 DBMET01307 | DBMET01301 | |
| 0.167 | 0.053 | 0.306 | MAO inhibitor | 0.254 0.027 DBMET01300 0.097 0.094 DBMET01301 0.127 0.071 DBMET01304 0.136 0.067 DBMET01306 0.102 0.088 DBMET01302 0.128 0.07 DBMET01303 0.306 0.019 DBMET01307 | DBMET01307 | |
| 0.152 | 0.044 | 0.253 | Protein-tyrosine phosphatase 1B inhibitor | 0.253 0.016 DBMET01300 0.11 0.07 DBMET01301 0.226 0.022 DBMET01304 0.186 0.033 DBMET01305 0.12 0.063 DBMET01306 0.115 0.066 DBMET01302 0.141 0.049 DBMET01307 | DBMET01300 | |
| 0.17 | 0.062 | 0.298 | Protein-tyrosine phosphatase inhibitor | 0.298 0.019 DBMET01300 0.136 0.094 DBMET01301 0.264 0.027 DBMET01304 0.214 0.042 DBMET01305 0.14 0.089 DBMET01306 0.136 0.094 DBMET01302 0.158 0.07 DBMET01307 | DBMET01300 | |
| 0.124 | 0.026 | 0.132 | Interleukin 12 antagonist | 0.131 0.021 DBMET01304 0.132 0.02 DBMET01305 0.113 0.037 DBMET01306 0.118 0.031 DBMET01307 | DBMET01305 | |
| 0.128 | 0.04 | 0.372 | Bronchodilator | 0.18 0.022 DBMET01300 0.322 0.008 DBMET01301 0.113 0.05 DBMET01304 0.123 0.043 DBMET01305 0.256 0.012 DBMET01306 0.372 0.006 DBMET01303 0.1 0.064 DBMET01307 | DBMET01303 | |
| 0.2 | 0.114 | 0.424 | Antioxidant | 0.424 0.031 DBMET01300 0.188 0.124 DBMET01301 0.229 0.096 DBMET01304 0.239 0.09 DBMET01305 0.212 0.106 DBMET01306 0.211 0.107 DBMET01302 0.182 0.13 DBMET01303 0.223 0.1 DBMET01307 | DBMET01300 | |
| 0.087 | 0.006 | 0.129 | Beta 2 adrenoreceptor agonist | 0.125 0.003 DBMET01300 0.127 0.003 DBMET01301 0.087 0.006 DBMET01304 0.083 0.008 DBMET01305 0.129 0.003 DBMET01306 0.065 0.03 DBMET01302 0.121 0.004 DBMET01303 0.075 0.013 DBMET01307 | DBMET01306 | |
| 0.102 | 0.022 | 0.12 | Phosphodiesterase III inhibitor | 0.12 0.015 DBMET01300 0.057 0.055 DBMET01301 0.081 0.035 DBMET01304 0.083 0.033 DBMET01305 0.062 0.05 DBMET01306 0.073 0.041 DBMET01302 0.086 0.031 DBMET01307 | DBMET01300 | |
| 0.104 | 0.031 | 0.33 | Telomerase inhibitor | 0.33 0.005 DBMET01300 0.063 0.06 DBMET01301 0.103 0.032 DBMET01304 0.08 0.044 DBMET01305 0.066 0.057 DBMET01306 0.087 0.04 DBMET01302 0.063 0.06 DBMET01303 0.1 0.033 DBMET01307 | DBMET01300 | |
| 0.075 | 0.003 | 0.276 | Thyroid hormone agonist | 0.276 0.001 DBMET01300 0.066 0.004 DBMET01301 0.07 0.003 DBMET01304 0.166 0.002 DBMET01305 0.082 0.003 DBMET01306 0.053 0.004 DBMET01302 0.063 0.004 DBMET01303 0.045 0.005 DBMET01307 | DBMET01300 | |
| 0.165 | 0.094 | 0.246 | Hepatoprotectant | 0.246 0.044 DBMET01300 0.148 0.112 DBMET01301 0.195 0.068 DBMET01304 0.192 0.07 DBMET01305 0.158 0.101 DBMET01306 0.151 0.109 DBMET01307 | DBMET01300 | |
| 0.089 | 0.018 | 0.089 | Phosphodiesterase 1B inhibitor | 0.079 0.023 DBMET01300 0.081 0.022 DBMET01302 0.062 0.039 DBMET01307 | ||
| 0.115 | 0.05 | 0.199 | Xanthine oxidase inhibitor | 0.162 0.03 DBMET01300 0.199 0.02 DBMET01304 0.152 0.034 DBMET01305 | DBMET01304 | |
| 0.209 | 0.146 | 0.231 | Nootropic | 0.231 0.124 DBMET01302 | DBMET01302 | |
| 0.076 | 0.014 | 0.136 | Beta 2 adrenoreceptor antagonist | 0.082 0.011 DBMET01300 0.103 0.008 DBMET01301 0.063 0.021 DBMET01304 0.073 0.015 DBMET01305 0.136 0.005 DBMET01306 0.094 0.008 DBMET01303 0.048 0.039 DBMET01307 | DBMET01306 | |
| 0.079 | 0.019 | 0.13 | Beta 1 adrenoreceptor antagonist | 0.081 0.018 DBMET01300 0.085 0.015 DBMET01301 0.065 0.03 DBMET01304 0.074 0.022 DBMET01305 0.13 0.006 DBMET01306 0.081 0.017 DBMET01303 0.072 0.024 DBMET01307 | DBMET01306 | |
| 0.142 | 0.083 | 0.205 | Phospholipase A2 inhibitor | 0.144 0.081 DBMET01300 0.205 0.04 DBMET01304 0.193 0.046 DBMET01305 0.148 0.076 DBMET01306 0.193 0.046 DBMET01302 0.171 0.059 DBMET01307 | DBMET01304 | |
| 0.204 | 0.151 | 0.281 | Insulysin inhibitor | 0.281 0.071 DBMET01300 0.229 0.118 DBMET01304 0.262 0.086 DBMET01305 | DBMET01300 | |
| 0.094 | 0.043 | 0.094 | Inducible nitric-oxide synthase inhibitor | 0.087 0.051 DBMET01301 | ||
| 0.058 | 0.013 | 0.077 | Integrin alpha5beta1 antagonist | 0.056 0.014 DBMET01304 0.077 0.007 DBMET01305 0.049 0.019 DBMET01306 0.048 0.02 DBMET01307 | DBMET01305 | |
| 0.123 | 0.079 | 0.138 | Phosphodiesterase inhibitor | 0.138 0.067 DBMET01307 | DBMET01307 | |
| 0.047 | 0.004 | 0.176 | Beta 1 adrenoreceptor agonist | 0.134 0.002 DBMET01300 0.176 0.002 DBMET01301 0.144 0.002 DBMET01304 0.062 0.004 DBMET01305 0.118 0.003 DBMET01306 0.031 0.008 DBMET01302 0.159 0.002 DBMET01303 0.033 0.006 DBMET01307 | DBMET01301 | |
| 0.04 | 0.004 | 0.272 | Beta 3 adrenoreceptor agonist | 0.113 0.003 DBMET01300 0.272 0.002 DBMET01301 0.185 0.002 DBMET01304 0.117 0.003 DBMET01305 0.17 0.002 DBMET01306 0.014 0.006 DBMET01302 0.248 0.002 DBMET01303 0.014 0.006 DBMET01307 | DBMET01301 | |
| 0.091 | 0.056 | 0.1 | Phosphodiesterase I inhibitor | 0.1 0.045 DBMET01300 0.084 0.068 DBMET01302 | DBMET01300 | |
| 0.07 | 0.039 | 0.12 | Beta adrenoreceptor antagonist | 0.082 0.025 DBMET01300 0.097 0.018 DBMET01301 0.064 0.047 DBMET01304 0.068 0.041 DBMET01305 0.12 0.01 DBMET01306 0.095 0.018 DBMET01303 0.062 0.052 DBMET01307 | DBMET01306 | |
| 0.052 | 0.023 | 0.103 | Phosphodiesterase 3B inhibitor | 0.103 0.01 DBMET01300 0.041 0.035 DBMET01301 0.04 0.036 DBMET01304 0.043 0.032 DBMET01305 0.045 0.029 DBMET01302 0.042 0.034 DBMET01307 | DBMET01300 | |
| 0.041 | 0.016 | 0.112 | Peroxisome proliferator-activated receptor delta agonist | 0.061 0.01 DBMET01304 0.112 0.005 DBMET01305 0.033 0.024 DBMET01307 | DBMET01305 | |
| 0.094 | 0.071 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.088 | 0.068 | 0.225 | MAO B inhibitor | 0.188 0.027 DBMET01300 0.089 0.066 DBMET01304 0.225 0.02 DBMET01307 | DBMET01307 | |
| 0.024 | 0.008 | 0.042 | Integrin alphaVbeta1 antagonist | 0.021 0.011 DBMET01304 0.042 0.005 DBMET01305 0.018 0.016 DBMET01306 0.018 0.016 DBMET01307 | DBMET01305 | |
| 0.019 | 0.004 | 0.189 | Thyroid hormone beta agonist | 0.189 0.002 DBMET01300 0.024 0.003 DBMET01301 0.016 0.004 DBMET01304 0.072 0.002 DBMET01305 0.024 0.003 DBMET01306 0.014 0.004 DBMET01302 0.022 0.004 DBMET01303 | DBMET01300 | |
| 0.036 | 0.024 | 0.086 | Retinoid X receptor agonist | 0.038 0.024 DBMET01300 0.086 0.006 DBMET01304 0.08 0.008 DBMET01305 | DBMET01304 | |
| 0.017 | 0.006 | 0.021 | Integrin beta6 antagonist | 0.018 0.005 DBMET01304 0.021 0.004 DBMET01305 0.016 0.007 DBMET01306 0.016 0.006 DBMET01307 | DBMET01305 | |
| 0.023 | 0.013 | 0.042 | Integrin beta5 antagonist | 0.027 0.01 DBMET01304 0.042 0.006 DBMET01305 0.021 0.014 DBMET01306 0.021 0.014 DBMET01307 | DBMET01305 | |
| 0.021 | 0.016 | 0.042 | Aggrecanase 2 inhibitor | 0.042 0.006 DBMET01300 0.021 0.016 DBMET01304 0.023 0.014 DBMET01305 | DBMET01300 | |
| 0.082 | 0.079 | 0.12 | 5-Lipoxygenase inhibitor | 0.12 0.05 DBMET01300 0.091 0.071 DBMET01304 0.111 0.056 DBMET01305 0.112 0.054 DBMET01307 | DBMET01300 | |
| 0.02 | 0.018 | 0.033 | Integrin alphaVbeta3 antagonist | 0.022 0.015 DBMET01304 0.033 0.007 DBMET01305 | DBMET01305 | |
| 0.021 | 0.027 | 0.023 | Phosphodiesterase 9A inhibitor | 0.023 0.021 DBMET01300 | DBMET01300 | |
| 0.048 | 0.054 | 0.081 | Thromboxane synthase inhibitor | 0.056 0.033 DBMET01300 0.064 0.022 DBMET01304 0.081 0.012 DBMET01305 | DBMET01305 | |
| 0.021 | 0.028 | 0.033 | Uridine phosphorylase inhibitor | 0.033 0.015 DBMET01300 | DBMET01300 | |
| 0.015 | 0.024 | 0.02 | Hexokinase stimulant | 0.02 0.014 DBMET01304 | DBMET01304 | |
| 0.052 | 0.07 | 0.066 | HIV-1 reverse transcriptase inhibitor | 0.066 0.053 DBMET01302 | DBMET01302 | |
| 0.055 | 0.072 | 0.088 | Phosphodiesterase 5A inhibitor | 0.088 0.033 DBMET01307 | DBMET01307 | |
| 0.184 | 0.204 | 0.196 | Calpain 2 inhibitor | 0.196 0.191 DBMET01300 | DBMET01300 | |
| 0.024 | 0.046 | 0.05 | Somatostatin 1 antagonist | 0.035 0.03 DBMET01300 0.05 0.02 DBMET01306 0.037 0.028 DBMET01303 | DBMET01306 | |
| 0.015 | 0.039 | 0.022 | Somatostatin 4 antagonist | 0.022 0.019 DBMET01306 | DBMET01306 | |
| 0.04 | 0.066 | 0.053 | Myc inhibitor | 0.053 0.04 DBMET01300 0.049 0.046 DBMET01304 | DBMET01300 | |
| 0.008 | 0.035 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 DBMET01300 | DBMET01300 | |
| 0.051 | 0.078 | 0.084 | Phosphodiesterase V inhibitor | 0.084 0.037 DBMET01307 | DBMET01307 | |
| 0.01 | 0.041 | 0.031 | Vitronectin receptor antagonist | 0.031 0.01 DBMET01305 | DBMET01305 | |
| 0.04 | 0.073 | 0.055 | Autotaxin inhibitor | 0.053 0.036 DBMET01300 0.055 0.033 DBMET01304 0.048 0.046 DBMET01305 | DBMET01304 | |
| 0.162 | 0.199 | 0.237 | Thyroid hormone antagonist | 0.237 0.132 DBMET01300 0.215 0.149 DBMET01305 | DBMET01300 | |
| 0.011 | 0.051 | 0.035 | Somatostatin 5 antagonist | 0.03 0.023 DBMET01304 0.035 0.021 DBMET01306 | DBMET01306 | |
| 0.04 | 0.085 | 0.055 | Collagenase 3 inhibitor | 0.055 0.048 DBMET01305 | DBMET01305 | |
| 0.101 | 0.159 | 0.258 | Growth hormone agonist | 0.258 0.041 DBMET01300 0.131 0.106 DBMET01305 | DBMET01300 | |
| 0.012 | 0.07 | 0.036 | Prostacyclin antagonist | 0.036 0.02 DBMET01305 | DBMET01305 | |
| 0.006 | 0.067 | 0.011 | Retinoic acid receptor gamma antagonist | 0.011 0.01 DBMET01304 | DBMET01304 | |
| 0.008 | 0.07 | 0.02 | Retinoic acid receptor antagonist | 0.02 0.011 DBMET01304 | DBMET01304 | |
| 0.104 | 0.168 | 0.204 | Adenylate cyclase stimulant | 0.204 0.012 DBMET01300 0.123 0.116 DBMET01304 0.131 0.1 DBMET01306 | DBMET01300 | |
| 0.037 | 0.104 | 0.061 | Leukotriene antagonist | 0.061 0.05 DBMET01305 | DBMET01305 | |
| 0.015 | 0.085 | 0.052 | Integrin antagonist | 0.052 0.027 DBMET01305 | DBMET01305 | |
| 0.034 | 0.111 | 0.049 | Bombesin 3 receptor antagonist | 0.049 0.048 DBMET01300 | DBMET01300 | |
| 0.065 | 0.142 | 0.131 | Estrogen-related receptor beta agonist | 0.131 0.006 DBMET01300 | DBMET01300 | |
| 0.046 | 0.13 | 0.1 | Somatostatin 1 agonist | 0.074 0.059 DBMET01300 0.1 0.034 DBMET01306 0.086 0.045 DBMET01303 | DBMET01306 | |
| 0.009 | 0.099 | 0.033 | CXC chemokine 2 receptor antagonist | 0.033 0.011 DBMET01300 | DBMET01300 | |
| 0.088 | 0.186 | 0.187 | Arachidonic acid antagonist | 0.187 0.046 DBMET01300 0.153 0.085 DBMET01305 | DBMET01300 | |
| 0.059 | 0.161 | 0.141 | Estrogen receptor beta antagonist | 0.141 0.018 DBMET01300 | DBMET01300 | |
| 0.153 | 0.265 | 0.308 | Apoptosis antagonist | 0.308 0.08 DBMET01300 0.243 0.135 DBMET01304 0.201 0.177 DBMET01305 | DBMET01300 | |
| 0.039 | 0.156 | 0.053 | Leukotriene C antagonist | 0.053 0.051 DBMET01305 | DBMET01305 | |
| 0.068 | 0.191 | 0.145 | Estrogen antagonist | 0.145 0.025 DBMET01300 | DBMET01300 | |
| 0.01 | 0.133 | 0.055 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.055 0.009 DBMET01300 | DBMET01300 | |
| 0.179 | 0.314 | 0.438 | Calcium channel L-type activator | 0.438 0.057 DBMET01300 0.388 0.089 DBMET01301 0.288 0.168 DBMET01304 0.436 0.058 DBMET01306 0.433 0.06 DBMET01303 | DBMET01300 | |
| 0.044 | 0.191 | 0.084 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.084 0.057 DBMET01300 | DBMET01300 | |
| 0.046 | 0.203 | 0.087 | Estrogen receptor alpha antagonist | 0.087 0.038 DBMET01300 | DBMET01300 | |
| 0.08 | 0.241 | 0.238 | Interleukin antagonist | 0.146 0.121 DBMET01305 0.238 0.066 DBMET01306 | DBMET01306 | |
| 0.128 | 0.294 | 0.191 | Nitric-oxide synthase stimulant | 0.191 0.105 DBMET01300 | DBMET01300 | |
| 0.139 | 0.312 | 0.291 | Histamine release inhibitor | 0.265 0.144 DBMET01300 0.291 0.128 DBMET01304 0.219 0.181 DBMET01305 | DBMET01304 | |
| 0.03 | 0.208 | 0.134 | Monophenol monooxygenase inhibitor | 0.134 0.054 DBMET01300 | DBMET01300 | |
| 0.035 | 0.224 | 0.056 | Bcl-xL inhibitor | 0.056 0.053 DBMET01300 | DBMET01300 | |
| 0.013 | 0.204 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.009 DBMET01300 | DBMET01300 | |
| 0.029 | 0.234 | 0.152 | Antiadrenergic | 0.118 0.046 DBMET01306 0.152 0.035 DBMET01303 | DBMET01303 | |
| 0.028 | 0.234 | 0.15 | Adrenaline antagonist | 0.116 0.045 DBMET01306 0.15 0.034 DBMET01303 | DBMET01303 | |
| 0.037 | 0.275 | 0.126 | Alpha 2b adrenoreceptor antagonist | 0.126 0.054 DBMET01300 | DBMET01300 | |
| 0.072 | 0.321 | 0.223 | Streptokinase A inhibitor | 0.223 0.119 DBMET01300 | DBMET01300 | |
| 0.013 | 0.273 | 0.043 | Dihydroorotase inhibitor | 0.043 0.033 DBMET01300 | DBMET01300 | |
| 0.049 | 0.325 | 0.157 | Dual specificity phosphatase inhibitor | 0.157 0.086 DBMET01300 | DBMET01300 | |
| 0.012 | 0.298 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 DBMET01300 | DBMET01300 | |
| 0.004 | 0.29 | 0.055 | Prostaglandin D2 antagonist | 0.055 0.006 DBMET01305 | DBMET01305 | |
| 0.087 | 0.375 | 0.24 | Cholesterol antagonist | 0.24 0.132 DBMET01304 | DBMET01304 | |
| 0.005 | 0.295 | 0.042 | Estradiol 17 beta-dehydrogenase inhibitor | 0.042 0.029 DBMET01300 | DBMET01300 | |
| 0.061 | 0.353 | 0.121 | Hemostatic | 0.121 0.113 DBMET01300 | DBMET01300 | |
| 0.091 | 0.392 | 0.217 | Transcription factor inhibitor | 0.217 0.211 DBMET01302 | DBMET01302 | |
| 0.008 | 0.32 | 0.044 | Oxytocin agonist | 0.044 0.028 DBMET01300 | DBMET01300 | |
| 0.067 | 0.38 | 0.177 | Neurotrophic factor enhancer | 0.177 0.101 DBMET01300 | DBMET01300 | |
| 0.008 | 0.323 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.044 DBMET01300 | DBMET01300 | |
| 0.05 | 0.376 | 0.225 | Free radical scavenger | 0.225 0.08 DBMET01300 | DBMET01300 | |
| 0.128 | 0.456 | 0.33 | 5 Hydroxytryptamine release inhibitor | 0.273 0.198 DBMET01300 0.33 0.133 DBMET01304 | DBMET01304 | |
| 0.04 | 0.37 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.06 DBMET01302 | DBMET01302 | |
| 0.007 | 0.355 | 0.109 | Prostaglandin antagonist | 0.109 0.015 DBMET01305 | DBMET01305 | |
| 0.073 | 0.432 | 0.21 | Gastrin inhibitor | 0.21 0.133 DBMET01300 | DBMET01300 | |
| 0.091 | 0.452 | 0.313 | GABA C receptor rho-3 antagonist | 0.313 0.107 DBMET01300 | DBMET01300 | |
| 0.034 | 0.401 | 0.119 | Electron transport complex I inhibitor | 0.118 0.049 DBMET01301 0.119 0.048 DBMET01303 | DBMET01303 | |
| 0.011 | 0.379 | 0.039 | Protein kinase (CK2) beta inhibitor | 0.039 0.013 DBMET01300 | DBMET01300 | |
| 0.023 | 0.407 | 0.096 | UDP-glucose 4-epimerase inhibitor | 0.096 0.066 DBMET01300 | DBMET01300 | |
| 0.011 | 0.415 | 0.087 | Phenylalanine 4-hydroxylase inhibitor | 0.087 0.032 DBMET01300 | DBMET01300 | |
| 0.028 | 0.446 | 0.103 | MAP kinase kinase 7 inhibitor | 0.103 0.01 DBMET01300 | DBMET01300 | |
| 0.025 | 0.468 | 0.09 | Triose-phosphate isomerase inhibitor | 0.09 0.059 DBMET01300 | DBMET01300 | |
| 0.017 | 0.482 | 0.098 | Creatine kinase inhibitor | 0.098 0.062 DBMET01300 | DBMET01300 | |
| 0.049 | 0.516 | 0.191 | Hypoxia-inducible factor 1 alpha inhibitor | 0.191 0.163 DBMET01300 | DBMET01300 | |
| 0.017 | 0.486 | 0.145 | Cystathionine beta-synthase inhibitor | 0.145 0.043 DBMET01300 | DBMET01300 | |
| 0.006 | 0.48 | 0.052 | Alcohol oxidase inhibitor | 0.052 0.043 DBMET01300 | DBMET01300 | |
| 0.028 | 0.507 | 0.149 | Platelet antagonist | 0.149 0.145 DBMET01305 | DBMET01305 | |
| 0.053 | 0.54 | 0.252 | Antibacterial | 0.252 0.175 DBMET01300 | DBMET01300 | |
| 0.038 | 0.535 | 0.197 | Transcription factor STAT3 inhibitor | 0.197 0.138 DBMET01300 | DBMET01300 | |
| 0.007 | 0.542 | 0.076 | Glutamate decarboxylase inhibitor | 0.076 0.048 DBMET01300 | DBMET01300 | |
| 0.018 | 0.554 | 0.124 | Alpha-N-acetylglucosaminidase inhibitor | 0.124 0.074 DBMET01300 | DBMET01300 | |
| 0.022 | 0.56 | 0.106 | DOPA decarboxylase inhibitor | 0.106 0.065 DBMET01300 | DBMET01300 | |
| 0.026 | 0.567 | 0.204 | Aldehyde oxidase inhibitor | 0.204 0.103 DBMET01300 | DBMET01300 | |
| 0.023 | 0.566 | 0.215 | Alpha-glucosidase inhibitor | 0.215 0.21 DBMET01300 | DBMET01300 | |
| 0.014 | 0.561 | 0.114 | GABA C receptor agonist | 0.114 0.054 DBMET01300 | DBMET01300 | |
| 0.003 | 0.564 | 0.045 | Dopamine D5 agonist | 0.045 0.022 DBMET01300 | DBMET01300 | |
| 0.014 | 0.579 | 0.078 | GABA B receptor agonist | 0.078 0.047 DBMET01300 | DBMET01300 | |
| 0.062 | 0.651 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.119 DBMET01300 | DBMET01300 | |
| 0.025 | 0.624 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.067 DBMET01300 | DBMET01300 | |
| 0.024 | 0.624 | 0.157 | Peroxidase inhibitor | 0.157 0.074 DBMET01300 | DBMET01300 | |
| 0.02 | 0.622 | 0.184 | DNA synthesis inhibitor | 0.184 0.148 DBMET01300 | DBMET01300 | |
| 0.02 | 0.633 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.131 DBMET01300 | DBMET01300 | |
| 0.057 | 0.69 | 0.246 | Tyrosine 3 hydroxylase inhibitor | 0.246 0.072 DBMET01300 | DBMET01300 | |
| 0.063 | 0.717 | 0.204 | Interleukin 2 agonist | 0.204 0.182 DBMET01305 | DBMET01305 | |
| 0.064 | 0.75 | 0.202 | 5 Hydroxytryptamine uptake stimulant | 0.202 0.147 DBMET01300 | DBMET01300 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |